Efficacy and safety of PD‑1 monoclonal antibody combined with interferon‑alpha 1b and anlotinib hydrochloride as the second-line therapy in patients with unresectable advanced melanoma: a retrospective study
crossref(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要